Yvette Zimmerman
Directeur Général chez Pantarhei Bioscience BV
Profil
Yvette Zimmerman currently works at Pantarhei Bioscience BV, as Chief Executive Officer & Director from 2019.
Ms. Zimmerman also formerly worked at Delphi Bioscience BV, as Director-Clinical Development, Kendle International LLC, as Manager-Global Projects in 2000, and Organon BioSciences NV, as Clinical Research Scientist in 2006.
Ms. Zimmerman received her graduate degree in 1993 from Maastricht University.
Postes actifs de Yvette Zimmerman
| Sociétés | Poste | Début |
|---|---|---|
Pantarhei Bioscience BV
 Pantarhei Bioscience BV Pharmaceuticals: MajorHealth Technology Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007. | Directeur Général | 01/01/2019 |
Anciens postes connus de Yvette Zimmerman
| Sociétés | Poste | Fin |
|---|---|---|
Organon BioSciences NV
 Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Directeur Technique/Scientifique/R&D | 01/01/2006 |
Kendle International LLC
 Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | 01/01/2000 |
Delphi Bioscience BV
 Delphi Bioscience BV Pharmaceuticals: MajorHealth Technology Delphi Bioscience BV develops health screening solutions for vaginal and cervical infections. It offers Delphi Screener, a self-sampling device which can be used by women or doctors, to collect reliable cervico-vaginal samples without the need for inserting a speculum during a pelvic exam. The company was founded in 2006 and is headquartered in Scherpenzeel, the Netherlands. | Corporate Officer/Principal | - |
Formation de Yvette Zimmerman
| Maastricht University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Commercial Services |
Organon BioSciences NV
Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
Pantarhei Bioscience BV
Pantarhei Bioscience BV Pharmaceuticals: MajorHealth Technology Pantarhei Bioscience BV is a bio-pharmaceutical company located in Zeist, Netherlands, that develops new treatments for women's health and reproductive endocrine oncology. Pantarhei's objective is to discover and develop safe and effective new treatments for women's health and reproductive endocrine oncology using existing targets, hormones, biologicals, and drugs. The Dutch company has extensive experience in the clinical development and creation of new drugs. Pantarhei develops patent-protected treatments up to phase II efficacy and safety, and after generating favorable human proof-of-concept efficacy and safety data, projects are sold or licensed-out to a (pharmaceutical) partner for final development (phase III), regulatory approval, and commercialization. The private company was founded in 2000 by Herjan Coelingh Bennink, and Yvette Zimmerman has been the CEO since 2007. | Health Technology |
Delphi Bioscience BV
Delphi Bioscience BV Pharmaceuticals: MajorHealth Technology Delphi Bioscience BV develops health screening solutions for vaginal and cervical infections. It offers Delphi Screener, a self-sampling device which can be used by women or doctors, to collect reliable cervico-vaginal samples without the need for inserting a speculum during a pelvic exam. The company was founded in 2006 and is headquartered in Scherpenzeel, the Netherlands. | Health Technology |
